Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results

被引：2

作者：

Silverberg, Jonathan, I ^{[1
]}

Guttman-Yassky, Emma ^{[2
,3
]}

Simpson, Eric L. ^{[4
]}

Papp, Kim A. ^{[5
,6
]}

Blauvelt, Andrew ^{[7
]}

Chu, Chia-Yu ^{[8
,9
]}

Hong, H. Chih-ho ^{[10
]}

Gold, Linda F. Stein ^{[11
]}

Bieber, Thomas ^{[12
]}

Kabashima, Kenji ^{[13
]}

Rosmarin, David ^{[14
]}

Gamelli, Amy ^{[15
]}

Calimlim, Brian ^{[15
]}

Vigna, Namita ^{[15
]}

Hu, Xiaofei ^{[15
]}

Yang, Yang ^{[15
]}

Wu, Xiaoqiang ^{[15
]}

Huang, Xiaohong ^{[15
]}

Suravaram, Smitha ^{[15
]}

Teixeira, Henrique D. ^{[15
]}

Raymundo, Eliza ^{[15
]}

Irvine, Alan D. ^{[16
]}

机构：

[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA

[2] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[3] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA

[4] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA

[5] Prob Med Res, Waterloo, ON, Canada

[6] K Papp Clin Res, Waterloo, ON, Canada

[7] Univ Toronto, Oregon Med Res Ctr, Dept Med, Div Dermatol, Portland, OR USA

[8] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan

[9] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[10] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[11] Henry Ford Hlth Syst, Dermatol Clin Res, West Bloomfield, MI USA

[12] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany

[13] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan

[14] Tufts Univ, Sch Med, Dept Dermatol, Boston, MA USA

[15] AbbVie Inc, N Chicago, IL USA

[16] Trinity Coll Dublin, Clin Med, Dublin, Ireland

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷

关键词：

upadacitinib; atopic dermatitis; Janus kinase; moderate-to-severe; week; 140;

D O I：

10.1093/bjd/ljad498.010

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

502

引用

页码：II8 / II8

页数：1